Series B in 2026: Bigger Checks, Harder Room

The average US Series B round hit $68 million in 2026, and that number carries more weight than it first appears. Crunchbase data shows early-stage funding, covering Series A and B combined, totalled $41.3 billion across 1,800 deals in Q1 alone, up 41% year-over-year. But deal count is tightening even as dollar volume climbs. That gap between capital deployed and companies funded is the real story of where venture is heading.

The pattern is consistent with what happened at seed, where funding rose 31% year-on-year to $12 billion, yet deal count dropped nearly a third. Larger checks. Fewer bets. Institutional investors are not spreading risk across more companies; they are concentrating it on fewer ones they believe in more deeply. At Series B, that logic is amplified. The bar to get in the room has risen, and the bar to close has risen faster.

The outliers make the average look modest. Kailera Therapeutics raised $600 million at Series B for oral obesity treatments. Physical Intelligence, an AI robotics startup, pulled in another $600 million in a round led by Google's CapitalG. Semiconductor funding saw a single-month peak of $14.6 billion in March. These are not typical rounds, but they set the psychological ceiling for what Series B can mean in 2026, and they pull investor attention upward toward the largest, most defensible opportunities.

For founders, the implications are direct. The flight-to-quality dynamic means institutional investors are arriving at Series B with sharper filters, not just around revenue, but around moat, market timing, and team density. A round that would have closed on $30 million of ARR two years ago now needs a cleaner story about category leadership. The compression of deal count while volume rises is a tell. Capital is available. Conviction is the scarce resource.

Over the next 12 months, expect this bifurcation to sharpen further. AI will continue to absorb a disproportionate share of Series B capital, but the more interesting pressure will come from sectors like semiconductors, climate infrastructure, and biotech, where large sovereign and corporate funds are writing growth-stage checks that compete directly with traditional VCs. Founders outside the AI core who can demonstrate structural advantages, not just traction, will find the window open. Those chasing the average will find the average has moved.